Carlo Alviggi
Overview
Explore the profile of Carlo Alviggi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
2654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alviggi C, Vigilante L, Cariati F, Conforti A, Humaidan P
Reprod Biol Endocrinol
. 2025 Mar;
23(Suppl 1):38.
PMID: 40059197
It is widely recognized that luteinizing hormone (LH) activity is pivotal during folliculogenesis. Nonetheless, the use of LH during ovarian stimulation remains a matter of debate. Indeed, women with good...
2.
Conforti A, Di Girolamo R, Guida M, Alviggi C, Casarini L
Reprod Biol Endocrinol
. 2025 Feb;
23(Suppl 1):29.
PMID: 40001128
Luteinizing hormone (LH) is fundamental to support development and reproduction. It acts through a receptor expressed in the gonads, modulating mitogenic, anti-apoptotic, and steroidogenic signals. LH is also marketed as...
3.
Di Spiezio Sardo A, Iorio G, Guerra S, Isaacson K, Kafetzis D, Conforti A, et al.
Fertil Steril
. 2025 Feb;
PMID: 39924098
Objective: To describe how hysteroscopic treatment of adenomyotic cystic lesions of the inner myometrium (IM), persisting after pharmacologic treatment, can improve reproductive outcomes in patients with multiple in vitro fertilization...
4.
Conforti A, Guadalupi G, Perruolo G, Auriemma R, Di Girolamo R, Carbone L, et al.
Minerva Obstet Gynecol
. 2024 Dec;
PMID: 39641286
Background: Intensive physical activity and rigid dietary regimes can act as modifiers of neuroendocrine axes in women, inducing hormonal disorders and related menstrual irregularities such as functional hypothalamic amenorrhea (FHA)....
5.
Alviggi C, Humaidan P, Fischer R, Conforti A, Dahan M, La Marca A, et al.
Reprod Biol Endocrinol
. 2024 Oct;
22(1):122.
PMID: 39385174
Background: Currently, there is no consensus on the optimal management of women with low prognosis in ART. In this Delphi consensus, a panel of international experts provided real-world clinical perspectives...
6.
Sunkara S, Schwarze J, Orvieto R, Fischer R, Dahan M, Esteves S, et al.
Fertil Steril
. 2024 Oct;
PMID: 39369933
Objective: To assess the adequate ovarian follicular development and oocyte recovery between ovarian potential (antral follicle count [AFC]) before the start of ovarian stimulation (OS) and oocyte quantity and quality...
7.
Conforti A, Carbone L, Di Girolamo R, Iorio G, Guida M, Campitiello M, et al.
Fertil Steril
. 2024 Sep;
123(3):457-476.
PMID: 39332623
Importance: The clinical management of women with diminished ovarian reserve (DOR) is a challenge in the field of medically assisted reproduction. Several therapeutic strategies have been proposed, but with mixed...
8.
Alviggi C, Iorio G, Serafino P, DellAquila M, Bifulco G, Giampaolino P
Fertil Steril
. 2024 Sep;
123(1):185-187.
PMID: 39265650
Objective: To describe the simultaneous laparoscopic approach for teratoma removal and oocyte retrieval performed under regional anesthesia in a woman, desiring to preserve fertility. The patient included in this video...
9.
Ubaldi F, Alviggi C, Garcia-Velasco J, Glujovsky D, Orvieto R, Cedars M
Fertil Steril
. 2024 Sep;
122(4):587-594.
PMID: 39254611
No abstract available.
10.
Cariati F, Conforti A, Esteves S, Alviggi C
Front Endocrinol (Lausanne)
. 2024 Aug;
15:1470608.
PMID: 39211447
No abstract available.